Cornercap Investment Counsel’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,020
| Closed | -$115K | – | 245 |
|
|
2024
Q4 | $115K | Buy |
+12,020
| New | +$115K | 0.04% | 462 |
|
|
2023
Q1 | – | Sell |
-67,457
| Closed | -$797K | – | 590 |
|
|
2022
Q4 | $797K | Buy |
+67,457
| New | +$797K | 0.14% | 328 |
|
|
2021
Q3 | – | Sell |
-19,975
| Closed | -$1.26M | – | 561 |
|
|
2021
Q2 | $1.26M | Buy |
19,975
+7,867
| +65% | +$495K | 0.14% | 222 |
|
|
2021
Q1 | $1.13M | Buy |
+12,108
| New | +$1.13M | 0.13% | 287 |
|
|
2020
Q4 | – | Sell |
-10,964
| Closed | -$1.13M | – | 487 |
|
|
2020
Q3 | $1.13M | Sell |
10,964
-2,368
| -18% | -$245K | 0.16% | 166 |
|
|
2020
Q2 | $1.05M | Sell |
13,332
-4,666
| -26% | -$369K | 0.17% | 166 |
|
|
2020
Q1 | $1.04M | Buy |
+17,998
| New | +$1.04M | 0.2% | 139 |
|
|
2019
Q1 | – | Sell |
-33,115
| Closed | -$1.96M | – | 417 |
|
|
2018
Q4 | $1.96M | Sell |
33,115
-6,415
| -16% | -$380K | 0.3% | 104 |
|
|
2018
Q3 | $2.6M | Sell |
39,530
-1,695
| -4% | -$112K | 0.34% | 84 |
|
|
2018
Q2 | $2.08M | Sell |
41,225
-2,285
| -5% | -$115K | 0.3% | 104 |
|
|
2018
Q1 | $2.29M | Sell |
43,510
-1,690
| -4% | -$89K | 0.33% | 94 |
|
|
2017
Q4 | $2.1M | Buy |
45,200
+565
| +1% | +$26.3K | 0.29% | 97 |
|
|
2017
Q3 | $1.81M | Buy |
+44,635
| New | +$1.81M | 0.25% | 109 |
|
|
2016
Q3 | – | Sell |
-13,025
| Closed | -$366K | – | 363 |
|
|
2016
Q2 | $366K | Buy |
+13,025
| New | +$366K | 0.07% | 309 |
|